{"id":5347,"date":"2026-06-26T09:44:15","date_gmt":"2026-06-26T09:44:15","guid":{"rendered":"https:\/\/cognitionconferences.com\/hivaids\/?post_type=committee&p=5347"},"modified":"2026-06-26T09:48:46","modified_gmt":"2026-06-26T09:48:46","slug":"rajgopal-govindarajan","status":"publish","type":"committee","link":"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/","title":{"rendered":"Rajgopal Govindarajan"},"content":{"rendered":"

Biography :<\/strong>
\nDr. Govindarajan\u2019s laboratory is interested in understanding and overcoming drug resistance in pancreatic cancer. His training is in the areas of animal sciences, cancer biology and drug transport-based pharmacokinetics, and has extensively used cell and animal models to evaluate nucleoside and oligonucleotide therapies. He also developed several new insights into the pharmacology and cytotoxicity of nucleoside analog drugs. Current focuses in his laboratory are to understand the epigenetic alterations in pancreatic cancer and to evaluate novel epigenetic reversal agents for effective pancreatic cancer treatment. Understanding epigenetic regulation of pluripotent stem cell factors in microRNA biogenesis is also of interest.<\/p>\n","protected":false},"featured_media":5348,"template":"","meta":{"_acf_changed":false},"class_list":["post-5347","committee","type-committee","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nRajgopal Govindarajan | The Ohio State University | USA<\/title>\n<meta name=\"description\" content=\"Dr. Govindarajan\u2019s laboratory is interested in understanding and overcoming drug resistance in pancreatic cancer. His training is in the areas of animal sciences, cancer biology and drug transport-based pharmacokinetics, and has extensively used cell and animal models to evaluate nucleoside and oligonucleotide therapies. He also developed several new insights into the pharmacology and cytotoxicity of nucleoside analog drugs. Current focuses in his laboratory are to understand the epigenetic alterations in pancreatic cancer and to evaluate novel epigenetic reversal agents for effective pancreatic cancer treatment. Understanding epigenetic regulation of pluripotent stem cell factors in microRNA biogenesis is also of interest.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rajgopal Govindarajan | The Ohio State University | USA\" \/>\n<meta property=\"og:description\" content=\"Dr. Govindarajan\u2019s laboratory is interested in understanding and overcoming drug resistance in pancreatic cancer. His training is in the areas of animal sciences, cancer biology and drug transport-based pharmacokinetics, and has extensively used cell and animal models to evaluate nucleoside and oligonucleotide therapies. He also developed several new insights into the pharmacology and cytotoxicity of nucleoside analog drugs. Current focuses in his laboratory are to understand the epigenetic alterations in pancreatic cancer and to evaluate novel epigenetic reversal agents for effective pancreatic cancer treatment. Understanding epigenetic regulation of pluripotent stem cell factors in microRNA biogenesis is also of interest.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/\" \/>\n<meta property=\"og:site_name\" content=\"Cognition Conferences\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-26T09:48:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cognitionconferences.com\/hivaids\/wp-content\/uploads\/2026\/06\/HIVAIDS-CONFERENCE-2026-OCMSSPEAKERS-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"200\" \/>\n\t<meta property=\"og:image:height\" content=\"240\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/committee\\\/rajgopal-govindarajan\\\/\",\"url\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/committee\\\/rajgopal-govindarajan\\\/\",\"name\":\"Rajgopal Govindarajan | The Ohio State University | USA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/committee\\\/rajgopal-govindarajan\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/committee\\\/rajgopal-govindarajan\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/HIVAIDS-CONFERENCE-2026-OCMSSPEAKERS-1.png\",\"datePublished\":\"2026-06-26T09:44:15+00:00\",\"dateModified\":\"2026-06-26T09:48:46+00:00\",\"description\":\"Dr. Govindarajan\u2019s laboratory is interested in understanding and overcoming drug resistance in pancreatic cancer. His training is in the areas of animal sciences, cancer biology and drug transport-based pharmacokinetics, and has extensively used cell and animal models to evaluate nucleoside and oligonucleotide therapies. He also developed several new insights into the pharmacology and cytotoxicity of nucleoside analog drugs. Current focuses in his laboratory are to understand the epigenetic alterations in pancreatic cancer and to evaluate novel epigenetic reversal agents for effective pancreatic cancer treatment. Understanding epigenetic regulation of pluripotent stem cell factors in microRNA biogenesis is also of interest.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/committee\\\/rajgopal-govindarajan\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/committee\\\/rajgopal-govindarajan\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/committee\\\/rajgopal-govindarajan\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/HIVAIDS-CONFERENCE-2026-OCMSSPEAKERS-1.png\",\"contentUrl\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/HIVAIDS-CONFERENCE-2026-OCMSSPEAKERS-1.png\",\"width\":200,\"height\":240},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/committee\\\/rajgopal-govindarajan\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rajgopal Govindarajan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/#website\",\"url\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/\",\"name\":\"Cognition Conferences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cognitionconferences.com\\\/hivaids\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rajgopal Govindarajan | The Ohio State University | USA","description":"Dr. Govindarajan\u2019s laboratory is interested in understanding and overcoming drug resistance in pancreatic cancer. His training is in the areas of animal sciences, cancer biology and drug transport-based pharmacokinetics, and has extensively used cell and animal models to evaluate nucleoside and oligonucleotide therapies. He also developed several new insights into the pharmacology and cytotoxicity of nucleoside analog drugs. Current focuses in his laboratory are to understand the epigenetic alterations in pancreatic cancer and to evaluate novel epigenetic reversal agents for effective pancreatic cancer treatment. Understanding epigenetic regulation of pluripotent stem cell factors in microRNA biogenesis is also of interest.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/","og_locale":"en_US","og_type":"article","og_title":"Rajgopal Govindarajan | The Ohio State University | USA","og_description":"Dr. Govindarajan\u2019s laboratory is interested in understanding and overcoming drug resistance in pancreatic cancer. His training is in the areas of animal sciences, cancer biology and drug transport-based pharmacokinetics, and has extensively used cell and animal models to evaluate nucleoside and oligonucleotide therapies. He also developed several new insights into the pharmacology and cytotoxicity of nucleoside analog drugs. Current focuses in his laboratory are to understand the epigenetic alterations in pancreatic cancer and to evaluate novel epigenetic reversal agents for effective pancreatic cancer treatment. Understanding epigenetic regulation of pluripotent stem cell factors in microRNA biogenesis is also of interest.","og_url":"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/","og_site_name":"Cognition Conferences","article_modified_time":"2026-06-26T09:48:46+00:00","og_image":[{"width":200,"height":240,"url":"https:\/\/cognitionconferences.com\/hivaids\/wp-content\/uploads\/2026\/06\/HIVAIDS-CONFERENCE-2026-OCMSSPEAKERS-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/","url":"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/","name":"Rajgopal Govindarajan | The Ohio State University | USA","isPartOf":{"@id":"https:\/\/cognitionconferences.com\/hivaids\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/#primaryimage"},"image":{"@id":"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/#primaryimage"},"thumbnailUrl":"https:\/\/cognitionconferences.com\/hivaids\/wp-content\/uploads\/2026\/06\/HIVAIDS-CONFERENCE-2026-OCMSSPEAKERS-1.png","datePublished":"2026-06-26T09:44:15+00:00","dateModified":"2026-06-26T09:48:46+00:00","description":"Dr. Govindarajan\u2019s laboratory is interested in understanding and overcoming drug resistance in pancreatic cancer. His training is in the areas of animal sciences, cancer biology and drug transport-based pharmacokinetics, and has extensively used cell and animal models to evaluate nucleoside and oligonucleotide therapies. He also developed several new insights into the pharmacology and cytotoxicity of nucleoside analog drugs. Current focuses in his laboratory are to understand the epigenetic alterations in pancreatic cancer and to evaluate novel epigenetic reversal agents for effective pancreatic cancer treatment. Understanding epigenetic regulation of pluripotent stem cell factors in microRNA biogenesis is also of interest.","breadcrumb":{"@id":"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/#primaryimage","url":"https:\/\/cognitionconferences.com\/hivaids\/wp-content\/uploads\/2026\/06\/HIVAIDS-CONFERENCE-2026-OCMSSPEAKERS-1.png","contentUrl":"https:\/\/cognitionconferences.com\/hivaids\/wp-content\/uploads\/2026\/06\/HIVAIDS-CONFERENCE-2026-OCMSSPEAKERS-1.png","width":200,"height":240},{"@type":"BreadcrumbList","@id":"https:\/\/cognitionconferences.com\/hivaids\/committee\/rajgopal-govindarajan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cognitionconferences.com\/hivaids\/"},{"@type":"ListItem","position":2,"name":"Rajgopal Govindarajan"}]},{"@type":"WebSite","@id":"https:\/\/cognitionconferences.com\/hivaids\/#website","url":"https:\/\/cognitionconferences.com\/hivaids\/","name":"Cognition Conferences","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cognitionconferences.com\/hivaids\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/cognitionconferences.com\/hivaids\/wp-json\/wp\/v2\/committee\/5347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cognitionconferences.com\/hivaids\/wp-json\/wp\/v2\/committee"}],"about":[{"href":"https:\/\/cognitionconferences.com\/hivaids\/wp-json\/wp\/v2\/types\/committee"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cognitionconferences.com\/hivaids\/wp-json\/wp\/v2\/media\/5348"}],"wp:attachment":[{"href":"https:\/\/cognitionconferences.com\/hivaids\/wp-json\/wp\/v2\/media?parent=5347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}